JA Solar Signs Deal with Innovalight for SECIUM Solar Cells Manufacturing

JA Solar announced that it has signed a three-year agreement with Innovalight for the supply of silicon nanoparticle ink, to be used in the manufacturing of SECIUM solar cells. The company has planned to start the commercial volume manufacturing of the solar cells in the latter half of 2010, whereas the pilot production already commenced in May.

JA Solar has attained 18.9% conversion efficiency for the SECIUM solar cells. The Fraunhofer Institute for Solar Energy Systems, located in Germany, has authorized these results. The new solar cells deliver better spectral response when at shorter wavelengths than the standard solar cells. This enables the solar cells to deliver higher conversion efficiency, when compared to the regular solar cells.

Both the companies also announced that a strategic agreement has been signed to jointly develop solar cells that have conversion efficiencies more than 20%. The solar cell development will be undertaken at the R&D center of JA Solar in China and the headquarters of Innovalight in California.

JA Solar’s CEO, Dr. Peng Fang, stated that the company would continue to be at the top of solar cell technology through collaboration between their internal R&D group and other companies like Innovalight.

Source: http://www.jasolar.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.